Publicaciones en colaboración con investigadores/as de Universidad Católica San Antonio (8)

2024

  1. ESSENCE-Dock: A Consensus-Based Approach to Enhance Virtual Screening Enrichment in Drug Discovery

    Journal of Chemical Information and Modeling, Vol. 64, Núm. 5, pp. 1605-1614

2023

  1. Antimalarial phytochemicals as potential inhibitors of SARS-CoV-2 guanine N7-methyltransferase (nsp 14): an integrated computational approach

    Journal of Biomolecular Structure and Dynamics, Vol. 41, Núm. 11, pp. 5022-5044

  2. Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses

    Bioorganic Chemistry, Vol. 133

2022

  1. African derived phytocompounds may interfere with SARS-CoV-2 RNA capping machinery via inhibition of 2′-O-ribose methyltransferase: An in silico perspective

    Journal of Molecular Structure, Vol. 1262

  2. Hydroxybenzoic Acids as Acetylcholinesterase Inhibitors: Calorimetric and Docking Simulation Studies

    Nutrients, Vol. 14, Núm. 12

2021

  1. The fda‐approved antiviral raltegravir inhibits fascin1‐dependent invasion of colorectal tumor cells in vitro and in vivo

    Cancers, Vol. 13, Núm. 4, pp. 1-22

2020

  1. New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells

    Experimental and Molecular Medicine, Vol. 52, Núm. 2, pp. 281-292

  2. Novel anti-invasive properties of a Fascin1 inhibitor on colorectal cancer cells

    Journal of Molecular Medicine, Vol. 98, Núm. 3, pp. 383-394